Condition used
Product Isolated yield 3a-e X Observation of byproducts. Additional notes Reaction was carried out as reported in reference. 4 Poor conversion is observed 12 2j R, X = H, R 1 = Ti(OPr) 4 , Toluene, reflux 3j: 0 % (n = 1) Discussion about the reduction of cyanide reaction: The low yields in the reduction of indole acetonitrile to corresponding amine are presumably duo to the presence of active methylene group. As previously suggested by Singaram group, 1, 2 the reducing agents may have been acting competitively as bases to abstract the proton from active methylene group leading to ketimine type of reactive intermediates, which could undergo self dimerization or polymerization leading to inseparable mixture of byproducts. As a result, the yield of expected amine products was low to moderate.
Further optimization is needed to improve the yield of this reaction.
Supporting Table S2 . Predicted ADMET properties of the selected four compounds by QikProp 3.5 (http://www.schrodinger.com) a QPlog S -aqueous solubility (log M) (favorable range -6.5-0.5) QPlogPo/w -octanol/water partition coefficient (favorable range -2.0-6.5) QPLogBB -brain/blood partition coefficient (-3.0-1.2) QPlog HERG -IC 50 for blocking HERG channels (concern below -5.0) # metab -number of likely metabolic reactions (1-8) QPPCaco -Gut-blood barrier permeability (<25 poor, >500 great) Rule of Five -number of violations of Lipinski's rule of five (fewer is better) # rtvfg -number of reactive functional groups (fewer is better) Human oral absorption (HOA) -qualitative metric (1, 2 or 3, low, medium or high) Compd. 
Supporting information text
Compound Synthesis.
Intermediates 2a, c-f were synthesized by the method described for 2b in the main text. 2- Synthesis of compounds 2k, 2l and 2m are described in the main text.
2-(

2-(2-(((1-Methylpiperidin-4-yl)amino)methyl)-1H-indol-1-yl)acetonitrile (2f
2-(2-Methylbenzofuran-3-yl)acetonitrile (2g)
Methyl (E)-3-(4-hydroxy-3,5-dimethoxyphenyl) 
Methyl (E)-3-(4-(2-(dimethylamino)ethoxy)-3,5-dimethoxyphenyl)acrylate (2p). This was
synthesized by the procedure described for 2l in the main text, from compounds 2o and 2-dimethylaminoethylethanol. 
(E)-3-(4-(2-(Dimethylamino)ethoxy)-3,5-dimethoxyphenyl)acrylic acid (2q).
This was synthesized by the procedure described for 2m. But, upon completion of the hydrolysis of ester, reaction mixture was adjusted to pH 5, then concentrated to dryness and used for next reaction to synthesize 6k (see below). Likewise, starting materials, (E)-3-(4-(3-(dimethylamino) 
propoxy)phenyl)acrylic acid, and (E)-3-(4-(2-(dimethylamino)ethoxy)-
phenyl)acrylic acid were prepared and used for synthesis of 6l and 6m (see below). 
Synthesis of intermediates 3a-i.
2-(5-Fluoro-2-methyl-1H-indol-1-yl)ethanamine (3c
N-((1-(2-Aminoethyl)-1H-indol-2-yl)methyl)-1-methylpiperidin-4-amine (3f
2-(2-Methylbenzofuran-3-yl)ethanamine (3g
2-(3-((Dimethylamino)methyl)-2-methyl-1H-indol-1-yl)ethanamine (3j):
A solution of KBH 4 (192 mg, 3.55 mmol) and Raney nickel (0.23g excess) in ethanol (8 mL) was added compound 2j (202 mg, 0.9 mmol) and resulting was stirred over 48 hrs.
Conversion of the reactant to product is very poor, even with excess addition of the reagents. Filtered the solids and filtrate was concentrated and subjected to silica gel chromatography, eluting with 0-30% ethyl acetate in hexane to recover starting material (65% yield) and product 3j (~ 5% yield). Starting materials 3k, 3l and 3,4,5-trimethoxycinnamic acid (4a) and derivatives (4b-d), were purchased from commercial sources.
Synthesis of compounds 5b-z and 6a-q is carried out by the method described for 5d in the main text.
Characterization data -3-(3,4,5-trimethoxyphenyl)acrylamide (5a) .
Characterization data for this compound has been described before.
7 (E)- . 4, acrylamide (5k). -3-(3,4,5-trimethoxyphenyl)-acrylamide (5l (E)-N- -3-(3,4,5-trimethoxyphenyl) . 4, acrylamide (5p). (E)-N- (3, 4, acrylamide (5q). (E)-N- propyl) -3-(3,4,5-trimethoxyphenyl) acrylamide (5r). ( 4, N- (3, propanamide (5u). N- 4, .
(E)-3-(4-Methoxyphenyl)-N-(2-(2-(trifluoromethyl)-1H-indol-1-yl)ethyl)acrylamide (5e
(E)-3-(4-Fluoro-3,5-dimethylphenyl)-N-(2-(2-(trifluoromethyl)-1H-indol-1-yl)ethyl)-acrylamide (5f
(E)-N-(2-(2-Methyl-1H-indol-3-yl)ethyl)-3-(3,4,5-trimethoxyphenyl)-acrylamide (5g
(E)-3-(3,4-Dimethoxyphenyl)-N-(2-(2-methyl-1H-indol-3-yl)ethyl)acrylamide (5h
(E)-N-(2-(5,7-Difluoro-2-methyl-1H-indol-3-yl)ethyl)-3-(3,4,5-trimethoxyphenyl)-acrylamide (5i
(E)-3-(4-Fluoro-3,5-dimethylphenyl)-N-(2-(2-methyl-1H-indol-3-yl)ethyl)acrylamide (5j
(E)-N-
(E)-N-(2-(2-(Morpholinomethyl)-1H-indol-1-yl)ethyl)
amino)methyl)-1H-indol-1-yl)ethyl)
(E)-N-(2-(2-Methyl-3-(piperidin-1-ylmethyl)-1H-indol-1-yl)ethyl)-3-(3,4,5-trimethoxyphenyl)acrylamide (5n).
(E)-N-(2-(3-((Dimethylamino)methyl)-2-methyl-1H-indol-1-yl)ethyl)-3-(3,4,5-trimethoxyphenyl)acrylamide (5o).
(E)-N-
(E)-N-((2-Methyl-1H-indol-3-yl)methyl)-3-(3,4,5-trimethoxyphenyl)acrylamide (5s
Characterization data for this compound has been described before. 3-Amino-N- (2-(2-methyl-1H-indol-1-yl)ethyl)-3-(3,4,5-trimethoxyphenyl) propanamide N- 4, (S, E)- 4, (R, E)- 4, Synthesis and characterization data of 6a and 6c are described in the main text. , 5.27; N, 5.85; found; C, 60.28; H, 5.30; N, 5. 92 (E) phenyl)-N- (2-(2-methyl-1H-indol-1-yl) 2- ethyl (E)-3-(3,4,5-trimethoxyphenyl) acrylate (6h). (2-(2-methyl-1H-indol-1-yl) ethyl)cyclopropane- 1-carboxamide (6i) .
(E)-3-(4-(2-Hydroxyethoxy)-3,5-dimethoxyphenyl)-N-(2-(2-methyl-1H-indol-1-yl)ethyl)acrylamide (6f
(E)-3-(4-(2-Hydroxyethoxy)-3,5-dimethoxyphenyl)-N-(2-(2-(trifluoromethyl)-1H-indol-1-yl)ethyl)acrylamide (6g).
2-(4-Fluorophenyl)-N-
